In Michigan, 11 new medical conditions have been added to the list of approved ailments eligible for medical marijuana treatment
The majority of Medical Marijuana Review Panel members recommended that the 11 new conditions must be approved, the Department of Licensing and Regulatory Affairs (LARA) Director Shelly Edgerton announced on Monday.
The list now includes arthritis, autism, chronic pain, Parkinson’s disease, along with seven other ailments.
“With the changes in state law to include marijuana-infused products and the advancement of marihuana research, and upon the recommendation of the panel members, I’ve added these eleven conditions to the approved list,” Edgerton said. “I’d like to thank the members of the review panel for their hard work in discussing these petitions and making their recommendations.”
In total, twenty-two conditions were reviewed, but the other 11, which included asthma, depression, and anxiety were not approved.
With the addition of the 11 new conditions, the list now totals to 22 conditions, some of which have specific stipulations attached.
Chairman of the Safer Arizona Campaign, David Wisniewski, believes the initiative was not well supported by the medical marijuana market.
Safer Arizona has a target of 225,000 signatures but was only able to muster 75,000 by the given deadline date.
Despite the failure in Arizona, the trend to legalize marijuana is continuing in the United States. In early June, Oklahoma became the 30th US state to legalize medical marijuana and Vermont the ninth state to legalize recreational cannabis.